Evidence map›Paper›PMID 36811032›Full record

Article3 Biotech2023

Cloning, recombinant expression, purification, and functional characterization of AGAAN antibacterial peptide.

Ya'u Sabo Ajingi, Neeranuch Rukying, Nafiu Usman Jiddah, Yuichi Koga, Nujarin Jongruja

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Ya'u Sabo AjingiDepartment of Microbiology, Faculty of Science, King Mongkut's University of Technology (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Thonburi , 10140 Bangkok Thailand.ORCID 0000-0002-9691-4194
Neeranuch RukyingDepartment of Microbiology, Faculty of Science, King Mongkut's University of Technology (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Thonburi , 10140 Bangkok Thailand.ORCID 0000-0002-0235-3622
Nafiu Usman JiddahDepartment of Microbiology, Faculty of Science, King Mongkut's University of Technology (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Thonburi , 10140 Bangkok Thailand.ORCID 0000-0003-4185-3280
Yuichi KogaDepartment of Applied Chemistry, Faculty of Engineering, Okayama University of Science , Ridai-cho 1-1, Kita-ku, Okayama City, Okayama Japan.ORCID 0000-0003-1702-6488
Nujarin JongrujaDepartment of Microbiology, Faculty of Science, King Mongkut's University of Technology (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Thonburi , 10140 Bangkok Thailand.ORCID 0000-0002-8839-2568
King Mongkut's University of Technology Thonburi · THKano State University of Technology · NGOkayama University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recombinant version of the AGAAN antimicrobial peptide (rAGAAN) was cloned, expressed, and purified in this study. Its antibacterial potency and stability in harsh environments were thoroughly investigated. A 15 kDa soluble rAGAAN was effectively expressed in

Indexed as

Antibacterial peptidePropidium iodidePurificationRecombinant expressionStability

Identifiers

PMID36811032
PMCPMC9938847
OpenAlexW4321351072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.